Dicerna Pharmaceuticals Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the third quarter 2021 to a ratio of 10.24, above the company average. This is a clear sign of healthy business climate in the Major Pharmaceutical Preparations industry and improving liquidity at their respective customers, during the third quarter 2021. Average receivable collection period, for the Dicerna Pharmaceuticals Inc in Sep 30 2021 quarter, has decreased to 36 days, compared to 38 days, in the Jun 30 2021 quarter.

If we take a look into Healthcare sector 365 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Sep 30 2021 from 2643 to 2663.

What is Receivable Turnover Ratio?
What is Dicerna Pharmaceuticals Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

DRNA Receivables Turnover Ratio	(Sep 30 2021) III. Quarter	(Jun 30 2021) II. Quarter	(Mar 31 2021) I. Quarter	(Dec 31 2020) IV. Quarter	(Sep 30 2020) III. Quarter
Y / Y Receivable Change	23.83 %	26125 %	108.45 %	-82.68 %	67.6 %
Y / Y Revenue Change	28.81 %	2.2 %	39.89 %	478.47 %	508.28 %
Receivable Turnover Ratio (TTM)	10.24	9.64	10.02	12	2.37
DRNA's Total Ranking	# 2663	# 2643	# 2636	# 500	# 2634
Accounts Receivable average collection period days	36	38	36	30	154
Seq. Receivable Change	97.84 %	-89.94 %	-9.93 %	590.39 %	41800 %
Seq. Revenue Change	52.29 %	-13.16 %	16.23 %	-16.2 %	20.83 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 117
Healthcare Sector	# 366
Overall Market	# 2663

Receivable Turnover Ratio Statistics
High	Average	Low
0.26	0.1	0.01
(Sep 30 2021)		(Jun 30 2017)

DRNA Company Profile • Back to DRNA Efficiency Comparisons • Compare DRNA Receivables Turnover Ratio to its Competitors

Financial Statements
Dicerna Pharmaceuticals Inc 's Accounts Receivable	$ 6 Millions	Visit DRNA's Balance sheet
Dicerna Pharmaceuticals Inc 's Sales TTM	$ 193 Millions	Visit DRNA's Income Statement
Sources of DRNA's Revenues		Visit DRNA's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
DRNA's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
DRNA's Growth Rates	DRNA's Roa	DRNA's Inventory Turnover Ratio	DRNA's Dividend Comparisons
DRNA's Profitability Ratios	DRNA's Roi	DRNA's Asset Turnover Ratio	DRNA's Dividend Growth
DRNA's Valuation Ratios	DRNA's Roe	DRNA's Financial Strength Ratios	DRNA's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2021, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Sep 30 2021	Receivable at quarter ending Sep 30 2021
Cytomx Therapeutics Inc	78.55	$ 66.219 Millions	$ 0.843 Millions
Vystar Corporation	77.59	$ 30.264 Millions	$ 0.390 Millions
Zeo Scientifix Inc	77.25	$ 5.597 Millions	$ 0.072 Millions
Vistagen Therapeutics Inc	69.39	$ 1.468 Millions	$ 0.021 Millions
Lifevantage Corp	62.91	$ 218.578 Millions	$ 3.475 Millions
Lifemd Inc	61.34	$ 78.352 Millions	$ 1.277 Millions
Eton Pharmaceuticals Inc	61.08	$ 15.820 Millions	$ 0.259 Millions
Petvivo Holdings Inc	59.62	$ 0.015 Millions	$ 0.000 Millions
Sonida Senior Living Inc	56.86	$ 257.319 Millions	$ 4.525 Millions
Wearable Health Solutions, Inc.	56.79	$ 1.425 Millions	$ 0.025 Millions
Denali Therapeutics Inc	53.96	$ 352.962 Millions	$ 6.541 Millions
H cyte Inc	52.52	$ 1.751 Millions	$ 0.033 Millions
Cyclerion Therapeutics Inc	49.73	$ 3.543 Millions	$ 0.071 Millions
Xoma Royalty Corporation	49.68	$ 29.796 Millions	$ 0.600 Millions
Strata Critical Medical Inc	49.51	$ 67.785 Millions	$ 1.369 Millions
Nature s Sunshine Products inc	47.02	$ 427.888 Millions	$ 9.100 Millions
Agenus Inc	46.22	$ 306.668 Millions	$ 6.635 Millions
Nurix Therapeutics Inc	45.79	$ 29.043 Millions	$ 0.634 Millions
Sage Therapeutics Inc	45.75	$ 1,113.852 Millions	$ 24.347 Millions
Brookdale Senior Living Inc	45.13	$ 3,011.489 Millions	$ 66.735 Millions
Jrsis Health Care Corp	43.54	$ 43.911 Millions	$ 1.009 Millions
Arrowhead Pharmaceuticals Inc	43.46	$ 138.287 Millions	$ 3.182 Millions
Seres Therapeutics Inc	42.86	$ 155.270 Millions	$ 3.623 Millions
Vtv Therapeutics Inc	38.22	$ 10.395 Millions	$ 0.272 Millions
Celularity Inc	37.68	$ 27.402 Millions	$ 0.727 Millions
National Vision Holdings Inc	37.00	$ 2,098.370 Millions	$ 56.710 Millions
Ngm Biopharmaceuticals Inc	35.49	$ 76.690 Millions	$ 2.161 Millions
Immunogen inc	34.73	$ 127.662 Millions	$ 3.676 Millions
Electromedical Technologies Inc	34.21	$ 0.851 Millions	$ 0.025 Millions
Albireo Pharma inc	32.97	$ 10.774 Millions	$ 0.327 Millions

Date modified: 2026-08-29T17:23:04+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.